Tokyo, Japan

Setsuko Niitsuma

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Setsuko Niitsuma: A Pioneer in HSP90 Inhibitors

Introduction: Setsuko Niitsuma, based in Tokyo, Japan, is an accomplished inventor known for her significant contributions to the field of pharmaceuticals. With a background that has led her to secure one patent, she is making strides in developing treatments aimed at critical biological pathways.

Latest Patents: Niitsuma’s notable patent focuses on an HSP90 inhibitor, specifically a triazole derivative as represented by the general formula provided in the patent documentation. This innovation includes pharmacologically acceptable salts and prodrugs derived from the triazole derivatives. The compound's structure highlights an array of substitutes, offering potential for therapeutic applications, especially in combating diseases where HSP90 plays a pivotal role.

Career Highlights: Setsuko Niitsuma has dedicated her career to advancing drug development and has been an integral part of Nippon Kayaku Co., Ltd. Her expertise in medicinal chemistry has facilitated innovative research that directly impacts the pharmaceutical industry and patient care.

Collaborations: Throughout her professional journey, Niitsuma has collaborated closely with talented individuals like Hiroshi Kuramochi and Masaharu Nakamura. These partnerships foster a creative environment that has enabled groundbreaking discoveries in their shared pursuits.

Conclusion: Setsuko Niitsuma’s work exemplifies the spirit of innovation within the pharmaceutical sector. With her patent on HSP90 inhibitors, she continues to contribute to essential research that may lead to significant medical advancements. Her collaborations and dedication underscore the importance of teamwork in achieving milestones in scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…